CONELUM is a biotechnological startup founded in late 2012. With internationally recognized microbiological safety scientists in its core team, the company is dedicated to developing rapid microbiological diagnostic tests for food and drink industry companies. Its products, based on the protected EloKIT Technology, eliminate the cultivation step from microbiological diagnostics, providing more accurate and detailed results than traditional methods. This allows food companies to carry out more precise optimization of production, saving time and minimizing production risks, and economic losses. In September 2013, CONELUM received a €200.00K Seed Round investment from Imprimatur Capital Fund Management, further validating its potential in the Biotechnology, Health Care, and Industrial industries. The company is headquartered in Latvia.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | €200.00K | 1 |
|
11 Sep 2013 |
No recent news or press coverage available for CONELUM.
We care about your data, and we'd love to use cookies make your experience better.
